Skip to content

Independent GLP-1 journalism

On The JabDr. Nick Robertson, MD
On The Jab

The index

Topics

Fourteen hubs. Each one collects everything we have published on a single question, oldest reporting to newest.

Medications

Ozempic

Semaglutide for type 2 diabetes — and everything that followed.

Wegovy

Semaglutide at weight-management doses.

Mounjaro

Tirzepatide, the dual GIP/GLP-1 agonist.

Zepbound

Tirzepatide for obesity and sleep apnea.

Next Generation

Orforglipron, retatrutide, CagriSema and the oral wave.

Your Body

Side Effects

Nausea, reflux, gallbladder, pancreatitis — risk in proportion.

Muscle & Strength

Protecting lean mass through a 20% weight loss.

Nutrition

Eating well on a fraction of your former appetite.

Mental Health

Mood, food noise, and the psychology of rapid change.

Practical

Dosing & Titration

Escalation schedules, missed doses, and the art of going slow.

Cost & Insurance

US pricing, coverage fights, Medicare and cash programs.

Compounding

The gray market, the FDA, and how to judge a source.

Maintenance

Staying on, tapering off, and what happens after goal weight.

The Business

Policy & Industry

Lilly, Novo, the FDA, and the money moving underneath it all.

Supply & Shortages

Who can actually get a pen this month, and why that keeps changing.

Telehealth

The subscription clinics that now write a large share of American prescriptions.

The book · 14 chapters

The GLP-1 Handbook

Everything I tell my own patients before their first injection. 214 pages of what actually matters in the first year — dosing, side effects, food, muscle, cost, and the part nobody prepares you for: maintenance.

$4Less than your morning coffee.
Read the first chapter

Priced at four dollars because it should be affordable to everyone taking these drugs — not because it's worth four dollars. No upsell, no course, no supplement line.